1. Home
  2. ADXN

as of 12-03-2025 11:15am EST

$8.23
$0.76
-8.45%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.

Chart Type:
Time Range:
Founded: 2002 Country:
Switzerland
Switzerland
Employees: 2 City: N/A
Market Cap: 11.1M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 8.1K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.08 EPS Growth: N/A
52 Week Low/High: $6.51 - $12.05 Next Earning Date: 12-04-2025
Revenue: $198,824 Revenue Growth: -71.81%
Revenue Growth (this year): 86.57% Revenue Growth (next year): N/A

AI-Powered ADXN Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 70.59%
70.59%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: